Morrison Todd Hale Increases Stake in BioRestorative Therapies, Inc. to 7.7%
2025-12-19SEC Filing SCHEDULE 13G/A (0002027680-25-000006)
Todd Hale Morrison, a significant shareholder, has increased their beneficial ownership in BioRestorative Therapies, Inc. to 7.7% of the outstanding common stock. This change is based on the acquisition of 685,000 shares, bringing the total to this percentage as of December 18, 2025. The previous ownership was 0%. This filing, an amendment to a Schedule 13G, indicates that the shares were acquired and are held for investment purposes and not for the purpose of influencing the control of the issuer. The calculation is based on 8,876,242 shares outstanding as of November 12, 2025. Morrison has shared voting and dispositive power over these 685,000 shares.
Related industry:Biotechnology
Source:Original SEC Document â